161 related articles for article (PubMed ID: 38719848)
1. CSC
Ortiz RC; Amôr NG; Saito LM; Santesso MR; Lopes NM; Buzo RF; Fonseca AC; Amaral-Silva GK; Moyses RA; Rodini CO
Sci Rep; 2024 May; 14(1):10583. PubMed ID: 38719848
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Rao RS; Raju K L; Augustine D; Patil S
Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
4. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
[TBL] [Abstract][Full Text] [Related]
5. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
[TBL] [Abstract][Full Text] [Related]
6. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N
Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595
[TBL] [Abstract][Full Text] [Related]
7. Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
Custódio M; Pelissari C; Santana T; Trierveiler M
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1877-1883. PubMed ID: 29779037
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
9. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
12. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
[TBL] [Abstract][Full Text] [Related]
13. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of Cancer Stem Cells Marker ALDH1 and its Association with Tumor Budding in Oral Squamous Cell Carcinoma.
Marangon Junior H; Melo VVM; Caixeta ÂB; Souto GR; Souza PEA; de Aguiar MCF; Horta MCR
Head Neck Pathol; 2019 Dec; 13(4):535-542. PubMed ID: 30430416
[TBL] [Abstract][Full Text] [Related]
16. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
[TBL] [Abstract][Full Text] [Related]
17. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin, β-catenin, and α2β1 and α3β1 integrin expression in primary oral squamous cell carcinoma and its regional metastasis.
Soares MQ; Mendonça JA; Morais MO; Leles CR; Batista AC; Mendonça EF
Histol Histopathol; 2015 Oct; 30(10):1213-22. PubMed ID: 25857731
[TBL] [Abstract][Full Text] [Related]
20. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]